CITIUS ONCOLOGY, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q4 2023 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Citius Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2023 to Q4 2024.
  • Citius Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $1.81M, a 5.66% decline year-over-year.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $1.81M -$109K -5.66% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-14
Q4 2023 $1.92M Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.